Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.64

Margin Of Safety %

26

Put/Call OI Ratio

0.37

EPS Next Q Diff

EPS Last/This Y

-0.33

EPS This/Next Y

0.37

Price

25.33

Target Price

30.33

Analyst Recom

2

Performance Q

-12.37

Relative Volume

2.35

Beta

0.85

Ticker: SNN




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19SNN24.790.325.00787
2024-12-20SNN24.660.332.00791
2024-12-23SNN24.530.2310.80539
2024-12-24SNN24.440.2310.80539
2024-12-26SNN24.450.340.00598
2024-12-27SNN24.80.340.00599
2024-12-30SNN24.580.370.00564
2024-12-31SNN24.590.370.00564
2025-01-02SNN24.40.370.00564
2025-01-03SNN24.410.370.00564
2025-01-06SNN24.640.370.00564
2025-01-07SNN24.6N/AN/A0
2025-01-08SNN24.33N/AN/A0
2025-01-09SNN24.32N/AN/A0
2025-01-10SNN23.95N/AN/A0
2025-01-13SNN24.03N/AN/A0
2025-01-14SNN23.89N/AN/A0
2025-01-15SNN24.880.370.00565
2025-01-16SNN25.050.37999.99566
2025-01-17SNN25.30.370.00567
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19SNN24.78- 356.11.32
2024-12-20SNN24.65- 354.81.32
2024-12-23SNN24.54- 351.91.32
2024-12-24SNN24.44- 356.81.32
2024-12-26SNN24.46- 353.21.32
2024-12-27SNN24.80- 362.11.32
2024-12-30SNN24.59- 371.41.32
2024-12-31SNN24.58- 371.21.32
2025-01-02SNN24.40- 362.41.32
2025-01-03SNN24.42- 362.91.32
2025-01-06SNN24.63- 385.41.32
2025-01-07SNN24.60- 370.71.32
2025-01-08SNN24.32- 354.71.32
2025-01-09SNN24.32- 355.71.32
2025-01-10SNN23.95- 345.81.32
2025-01-13SNN24.03- 357.11.32
2025-01-14SNN23.88- 360.71.32
2025-01-15SNN24.86- 389.71.32
2025-01-16SNN25.05- 374.01.32
2025-01-17SNN25.33- 372.81.32
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19SNN0.00-4.040.66
2024-12-20SNN0.00-4.040.66
2024-12-23SNN0.00-4.750.66
2024-12-24SNN0.00-4.750.66
2024-12-26SNN0.00-4.750.70
2024-12-27SNN0.00-4.750.70
2024-12-30SNN0.00-4.490.70
2024-12-31SNN0.00-4.490.70
2025-01-02SNN0.00-4.490.70
2025-01-03SNN0.00-4.490.70
2025-01-06SNN0.00-1.380.70
2025-01-07SNN0.00-1.380.70
2025-01-08SNN0.00-1.380.70
2025-01-09SNN0.00-1.380.70
2025-01-10SNN0.00-1.380.70
2025-01-13SNN0.00-1.560.64
2025-01-14SNN0.00-1.560.64
2025-01-15SNN0.00-1.560.64
2025-01-16SNN0.00-1.560.64
2025-01-17SNN0.00-1.560.64
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-1.56

Beta

0.85

Average Sales Estimate Current Quarter

1538

Average Sales Estimate Next Quarter

1442

Fair Value

31.82

Quality Score

73

Growth Score

78

Sentiment Score

94

Actual DrawDown %

51.5

Max Drawdown 5-Year %

-55.1

Target Price

30.33

P/E

36.32

Forward P/E

12.92

PEG

3.38

P/S

1.96

P/B

2.12

P/Free Cash Flow

36.81

EPS

0.7

Average EPS Est. Cur. Y​

1.32

EPS Next Y. (Est.)

1.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.41

Relative Volume

2.35

Return on Equity vs Sector %

-13.2

Return on Equity vs Industry %

-6.7

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.09

EBIT Estimation

372.8
Smith & Nephew SNATS, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 18000
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
stock quote shares SNN – Smith & Nephew plc Stock Price stock today
news today SNN – Smith & Nephew plc stock forecast ,stock prediction 2023 2024 2025
marketwatch SNN – Smith & Nephew plc yahoo finance google finance
stock history SNN – Smith & Nephew plc invest stock market
stock prices SNN premarket after hours
ticker SNN fair value insiders trading